External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms
NCT07214545
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: Does eTNS reduce ADHD symptoms? Does eTNS improve core and associated features of ASD?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Attention Deficit Disorder With Hyperactivity (ADHD)
- Autism Spectrum Disorder (ASD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 7 to 14 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of California, San Francisco
- Last updated on ClinicalTrials.gov
- October 9, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- UCSF Nancy Friend Pritzker Psychiatry Building · San Francisco, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.